Modeling the 3D structure of GPCRs from sequence
✍ Scribed by Sharon Shacham; Maya Topf; Noa Avisar; Fabian Glaser; Yael Marantz; Shay Bar-Haim; Silvia Noiman; Zvi Naor; Oren M. Becker
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 377 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0198-6325
- DOI
- 10.1002/med.1019
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
G‐protein‐coupled receptors (GPCRs) are a large and functionally diverse protein superfamily, which form a seven transmembrane (TM) helices bundle with alternating extra‐cellular and intracellular loops. GPCRs are considered to be one of the most important groups of drug targets because they are involved in a broad range of body functions and processes and are related to major diseases. In this paper we present a new technology, named PREDICT, for modeling the 3D structure of any GPCR from its amino acid sequence. This approach takes into account both internal protein properties (i.e., the amino acid sequence) and the properties of the membrane environment. Unlike competing approaches, the new technology does not rely on the single known structure of rhodopsin, and is thus capable of predicting novel GPCR conformations. We demonstrate the capabilities of PREDICT in reproducing the known experimental structure of rhodopsin. In principle, PREDICT‐generated models offer new opportunities for structure‐based drug discovery towards GPCR targets. © 2001 John Wiley & Sons, Inc. Med Res Rev, 21, No. 5, 472–483, 2001
📜 SIMILAR VOLUMES
During a blind protein structure prediction experiment (the third round of the Critical Assessment of Techniques for Protein Structure Prediction; URL http://PredictionCenter.llnl.gov/ casp3/), four target proteins, T0047, T0048, T0055, and T0070, were modeled by comparison. These proteins display 6
## Abstract In relation to the prediction of allergenicity three aspects have to be discussed: IgE immunogenicity, IgE cross‐reactivity, and T‐cell cross‐reactivity. IgE immunogenicity depends largely on factors other than the protein itself: the context and dose and “history” of the protein by the
Homology or comparative modeling is aimed at modeling the three-dimensional structure of a target sequence of unknown structure using the framework of an already known fold. Traditionally, homology modeling has been applied to targets with clear sequence similarity to proteins of known structure. Be